Drug Research
Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19
Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19. The mutually exclusive collaboration...
Drug Research
Medicines Discovery Catapult helping advance Covid-19 testing
The Medicines Discovery Catapult will open a new dedicated laboratory at Bruntwood SciTech’s Alderley Park in Cheshire, making it one of the government’s national hubs for Covid-19 testing.
Medicines Discovery Catapult is also helping to co-ordinate the establishment of the...
Drug Research
Zymo Research Announces Partnership with Tecan for COVID-19 Viral RNA Extraction
Zymo Research announced a partnership with Tecan to launch a ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma, and serum. The DreamPrep™ NAP workstation, featuring Zymo Research’s Quick-DNA/RNA™ Viral MagBead Kit,...
Drug Research
Scientists on Standby portal launched to support the recruitment of overflow resource for the testing of COVID-19
Scientists on Standby has been rapidly conceptualised and launched in response to the COVID-19 crisis and in anticipation of the increasing pressure on UK diagnostic testing laboratories and facilities in the coming weeks and months. The portal enables scientists...
Drug Research
N4 Pharma exploring how Nuvec can be used to help fight COVID-19
N4 Pharma Plc , the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, announces that it will be undertaking a proof of concept research project using a Covid-19 DNA plasmid for the purpose...
Drug Research
Cobra Biologics announces collaboration to develop Covid-19 DNA vaccine
Cobra Biologics and the Karolinska Institutet (KI) have been awarded €3 million in emergency funding to take a DNA vaccine for Covid-19 through phase I clinical trial testing.
The funding, awarded by Horizon 2020, comes as part of the OPENCORONA...
Drug Research
Amidst Controversy, FDA Issues EUA Allowing Anti-Malaria Drugs to Be Used to Treat COVID-19
Only time will tell if any of the assays, medical equipment or drugs the U.S. FDA is approving for use during the COVID-19 pandemic under Emergency Use Authorization (EUA) will turn out to be ineffective or substandard. Now, the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.